Effects of Smoking on Systemic and Intrarenal Hemodynamics: Influence on Renal Function

Journal of the American Society of Nephrology

Volumn 15, Issue 1 SUPPL., 2004, Pages

  Orth, Stephan R ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Dialysezentrum Schwandorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING;

EID: 0348141777     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.asn.0000093461.36097.d5     Document Type: Conference Paper

References (62)

1. Hesse E: Der Einflup des Rauchens auf den Kreislauf. Dtsch Arch Klin Med 89: 565-575, 1907
2. Lickint F: Tabak und Organismus. Handbuch der gesamten Tabakkunde, Stuttgart, Hippocrates-Verlag, 1939
3. Christiansen JS: Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1: 146-149, 1978
4. Orth SR, Ritz E, Schrier RW: The renal risks of smoking. Kidney Int 51: 1669-1677, 1997
5. Green MS, Jucha E, Luz Y: Blood pressure in smokers and nonsmokers: Epidemiologic findings. Am Heart J 111: 932-940, 1986
6. Orth SR: Smoking: A renal risk factor. Nephron 86: 12-26, 2000
7. Orth SR, Viedt C, Ritz E: Adverse effects of smoking in the renal patient. Tohoku J Exp Med 194: 1-15, 2001
8. Mann SJ, James GD, Wang RS, Pickering T: Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case control study. JAMA 265: 2226-2228, 1991
9. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, Tichet J: The risk of hypertension in men: Direct and indirect effects of chronic smoking. J Hypertens 20: 187-193, 2002
10. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G: Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 90: 248-253, 1994
11. Halimi JM, Philippon C, Mimran A: Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 13: 940-944, 1998.
12. Ritz E, Benck U, Franck E, Keller C, Seyfarth M, Clorius J: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 10: 1798-1804, 1998
13. Ritz E, Benck U, Orth SR: Acute effects of cigarette smoking on renal hemodynamics. Contrib Nephrol 130: 31-38, 2000
14. Benck U, Clorius JH, Zuna I, Ritz E: Renal hemodynamic changes during smoking: Effects of adrenoreceptor blockade. Eur J Clin Invest 29: 1010-1018, 1999
15. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13: 1663-1672, 2002
16. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE: Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med 38: 1107-1110, 2000
17. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE: Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 249: 519-526, 2001
18. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133: 585-591, 2000
19. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, Lebranchu Y, Tichet J: Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 58: 1285-1292, 2000
20. Hogan SL, Colindres RE, Cai J, Coresh J: Association of smoking with albuminuria in a cross-sectional probability sample of U.S. adults [Abstract]. J Am Soc Nephrol 12: 209A, 2001
21. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, Atkins RC: Smoking is associated with renal impairment and proteinuria in the normal population: The Aus-Diab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 40: 704-712, 2002
22. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Influence of smoking and obesity on the development of proteinuria. Kidney Int 62: 956-962, 2002
23. Orth SR, Stöckmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schäfer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926-931, 1998
24. Stengel B, Couchoud C, Cenee S, Hemon D: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 57: 2519-2526, 2000
25. Nielsen MM, Hjøllund E: Smoking and diabetic microangiopathy. Lancet 2: 533-534, 1978
26. Orth SR, Ritz E: Adverse effect of smoking on renal function in the general population: Are men at higher risk? Am J Kidney Dis 40: 864-866, 2002
27. Kamimura M, Orth SR: Altered tubular albumin degradation in the pathogenesis of albuminuria: Additional experimental evidence challenging the paradigm of glomerular capillary leakage. J Hypertens 21: 269-271, 2003
28. Whelton PK, Randall B, Neaton J, Stamler J, Brancati FL, Klag MJ: Cigarette smoking and ESRD incidence in men screened for the MRFIT [Abstract]. J Am Soc Nephrol 6: 408A, 1995
29. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG: Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57: 2072-2079, 2000
30. Goetz FC, Jacobs DR Jr, Chavers B, Roel J, Yelle M, Sprafka JM: Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 145: 91-102, 1997
31. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
32. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12: 218-225, 2001
33. Ruilope LM, van Veldhuisen DJ, Ritz E, Lüscher TF: Renal function: The Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38: 1782-1787, 2001
34. Mimran A, Ribstein J, DuCailar G, Halimi JM: Albuminuria in normals and essential hypertension. J Diabetes Complications 8: 150-156, 1994
35. Hörner D, Fliser D, Klimm HP, Ritz E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14: 655-660, 1996
36. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, Yusuf S: Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23[Suppl 2]: B35-B39, 2000
37. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. J Hypertens 20: 405-412, 2002
38. Regalado M, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35: 687-694, 2000
39. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25: 587-594, 1995
40. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P: Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabet Med 11: 666-669, 1994
41. Borch-Johnsen K, Nissen H, Henriksen E, Kreiner S, Salling N, Deckert T, Nerup J: The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med 4: 201-210, 1987
42. Mackin P, Macleod JM, New JP, Marshall SM: Renal function in long-duration type I diabetes. Diabetes Care 19: 249-251, 1996
43. Unuigbe EI, Omeife H, Edema T, Ukoli FA: Microalbuminuria and associated factors in newly diagnosed diabetics. Niger Postgrad Med J 8: 187-192, 2001
44. Chuahirun T, Khanna A, Kimball K, Wesson DE: Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 41: 13-21, 2003
45. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE: A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2: 41-45, 1996
46. Perna A, Iordache BE, Bettinaglio P, Ruggenenti P, Noris M, Galbusera A, Caprioli J, Rubis N, Gritti D, Fassi A, Remuzzi G: DD ACE genotype and smoking cluster with high-normal albuminuria: A cross-sectional analysis in 1209 normo-albuminuric type 2 diabetics enrolled in the BErgamo NEphrologic Diabetes Complications Trial (BENEDICT) [Abstract]. J Am Soc Nephrol 12: 154A, 2001
47. Baggio B, Budakovic A, Casara D, Gambaro G, Saladini G, Piccoli A, Verlato F: Renal involvement in subjects with peripheral atherosclerosis. J Nephrol 14: 286-292, 2001
48. Auerbach O, Hammond EC, Garfinkel L: Thickening of walls of arterioles and small arteries in relation to age and smoking habits. N Engl J Med 278: 980-984, 1968
49. Auerbach O, Carter HW, Garfinkel L, Hammond EC: Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest 70: 697-705, 1976
50. Black HR, Zeevi GR, Silten RM, Walker Smith GJ: Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 34: 173-179, 1983
51. Oberai B, Adams CW, High OB: Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis 52: 185-190, 1984
52. Tracy RE, Malcom GT, Oalmann MC, Newman WP 3rd, Guzman MA: Nephrosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease. Mod Pathol 7: 301-309, 1994
53. Lhotta K, Rumpelt JH, König P, Mayer G, Kronenberg F: Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 61: 648-654, 2002
54. Bos WJ, Demircan MM, Weening JJ, Krediet RT, van der Wal AC: Renal vascular changes in renal disease independent of hypertension. Nephrol Dial Transplant 16: 537-541, 2001
55. Baggio B, Budakovic A, Vestra MD, Saller A, Bruseghin M, Fioretto P: Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 13: 2730-2736, 2002
56. Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR: Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 61: 2090-2098, 2002
57. Jorenby DE: Smoking cessation strategies for the 21st century. Circulation 104: E51-E52, 2001
58. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R: Pharmacokinetics of nicotine in kidney failure. Clin Pharmacol Ther 68: 250-260, 2000
59. Foley RN, Herzog CA, Collins AJ: Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study. Kidney Int 63: 1462-1467, 2003
60. Orth SR, Uehlinger DE: Smoking and dialysis: A dreadful scenario for the cardiovascular system? Kidney Int 63: 1580-1581, 2003
61. Culleton BF, Wilson PW: Cardiovascular disease: Risk factors, secular trends, and therapeutic guidelines. J Am Soc Nephrol 9[12 Suppl]: S5-S15, 1998
62. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, Buring JE, Hennekens CH: The primary prevention of myocardial infarction. N Engl J Med 326: 1406-1416, 1992